Market Tracker

07/27 3:14pm ET

Impax Laboratories Inc (NASDAQ:IPXL)

31.35
BATS BZX Real-Time Price
As of 3:13pm ET
 +0.56 / +1.82%
Today’s Change
27.62
Today|||52-Week Range
50.62
-26.68%
Year-to-Date
4 Low P/CF Stocks to Improve Your Value Investing
Jul 22 / Zacks.com - Paid Partner Content
Teva Raises Q2 Guidance; to Unveil 2016-2019 View
Jul 13 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close30.79
Today’s open30.74
Day’s range30.74 - 31.35
Volume30,271
Average volume (3 months)639,692
Market cap$2.3B
Dividend yield--
Data as of 3:13pm ET, 07/27/2016

Growth & Valuation

Earnings growth (last year)-33.33%
Earnings growth (this year)+22.05%
Earnings growth (next 5 years)+16.30%
Revenue growth (last year)+44.36%
P/E ratio64.4
Price/Sales3.58
Price/Book2.11

Competitors

 Today’s
change
Today’s
% change
RAREUltragenyx Pharmaceu...+3.61+6.31%
GLPGGalapagos NV+0.22+0.41%
MDCOMedicines Co+2.37+6.69%
IRWDIronwood Pharmaceuti...+0.36+2.54%
Data as of 3:14pm ET, 07/27/2016

Financials

Last reporting dateJuly 26, 2016
EPS forecast (this quarter)$0.33
Annual revenue (last year)$860.5M
Annual profit (last year)$39.0M
Net profit margin4.53%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
George Frederick Wilkinson
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts